Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Truvada prevents HIV infection in men who have sex with men

Dec. 14, 2010

Polyphor divulges new chemokine CXCR4 receptor antagonists

Dec. 10, 2010

Theratechnologies and sanofi-aventis enter agreement for Egrifta

Dec. 9, 2010

Expansion of phase IIa study of GeoVax's HIV/AIDS vaccine

Dec. 9, 2010

Argos doses patients in phase IIb Arcelis personalized HIV immunotherapy trial

Dec. 3, 2010

Mymetics' HIV vaccine shows encouraging preliminary phase I results

Dec. 2, 2010

Katholieke Universiteit Leuven discloses new HIV-1 reverse transcriptase substrates

Nov. 29, 2010

Idenix receives milestone for GSK-2248761 trial in HIV

Nov. 25, 2010

Gilead submits NDA to FDA for single-tablet Truvada/TMC-278 combination

Nov. 24, 2010

Bionor Pharma reverses decision to terminate development of Vacc-4x

Nov. 23, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...